download chevron-down chevron-right chevron-with-circle-down chevron-with-circle-up check circle-with-minus circle-with-plus export help-with-circle inbox link mail old-phone star-outlined star user v-card close close close Back to top
Top

Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS Measure ID
CMS144v6
Version
6
NQF Number
0083
Measure Description

Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed beta-blocker therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge

Initial Population

All patients aged 18 years and older with a diagnosis of heart failure

Denominator Statement

Equals Initial Population with a current or prior LVEF < 40%

Denominator Exclusions

None

Numerator Statement

Patients who were prescribed beta-blocker therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge

Numerator Exclusions

Not Applicable

Denominator Exceptions

Documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, low blood pressure, fluid overload, asthma, patients recently treated with an intravenous positive inotropic agent, allergy, intolerance, other medical reasons).

Documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons).

Documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the healthcare system).

Next Version
Measure Scoring
Measure Type
Improvement Notation

Higher score indicates better quality

Guidance

LVEF < 40% corresponds to qualitative documentation of moderate dysfunction or severe dysfunction.

A range value should satisfy the logic requirement for 'Ejection Fraction' as long as the ranged observation value clearly meets the less than 40% threshold noted in the denominator logic. A range that is inclusive of or greater than 40% would not meet the measure requirement.

To satisfy this measure, it must be reported for all heart failure patients at least once during the measurement period if seen in the outpatient setting. If the patient has an eligible inpatient discharge during the measurement period, as defined in the measure logic, it is expected to be reported at each hospital discharge.

Beta-blocker therapy:

-For patients with prior LVEF < 40%, beta-blocker therapy should include bisoprolol, carvedilol, or sustained release metoprolol succinate.

The requirement of "Count >=2 Encounter, Performed" is to establish that the eligible professional or eligible clinician has an existing relationship with the patient.

Notes

Value Set content updated Sept 2017

Specifications

Attachment Size
CMS144v6.html 29.89 KB
CMS144v6.xml 114.24 KB
CMS144v6_SimpleXML.xml 37.71 KB
EP_EC_CMS144v6_NQF0083_HF_BB.zip 28.84 KB
CMS144v6_TRN_2018.xlsx 18.35 KB

Release Notes

Header

  • ​Incremented eMeasure Version number.

    Measure Section: eMeasure Version number

    Source of Change: Measure Lead

  • Reverted to the parent NQF Number, 0083, for CMS documentation per guidance from National Quality Forum.

    Measure Section: NQF Number

    Source of Change: Measure Lead

  • ​Updated Copyright.

    Measure Section: Copyright

    Source of Change: Annual Update

  • ​Updated Disclaimer.

    Measure Section: Disclaimer

    Source of Change: Measure Lead

  • Updated Guidance.

    Measure Section: Guidance

    Source of Change: Measure Lead

  • Added Guidance to provide clarification on what threshold range value(s) would satisfy the logic requirement for 'Ejection Fraction.'.

    Measure Section: Guidance

    Source of Change: Measure Lead

Logic

  • Replaced value set Beta Blocker Therapy Ingredient (2.16.840.1.113883.3.526.3.1493​) with value set Beta Blocker Therapy for LVSD (2.16.840.1.113883.3.526.3.1184) in the 'Medication, Order not done' logic. As a result, the Data Criteria (QDM Data Element) 'Medication, Order: Beta Blocker Therapy Ingredient' has been removed.

    Measure Section: Denominator Exceptions

    Source of Change: JIRA (CQM-1812)

Value Set

The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets.

  • Removed term types BN, PIN, and MIN from value set Beta Blocker Therapy Ingredient (2.16.840.1.113883.3.526.3.1493​).

    Measure Section: QDM Data Elements

    Source of Change: JIRA (CQM-1812)

  • Value set Patient Reason (2.16.840.1.113883.3.526.3.1008): Added 1 SNOMEDCT code (713247000) and deleted 1 SNOMEDCT code (258147002).

    Measure Section: QDM Data Elements

    Source of Change: Annual Update

  • Value set Ejection Fraction (2.16.840.1.113883.3.526.3.1134): Added 8 LOINC codes (77889-4, 77890-2, 77891-0, 77892-8, 79990-8, 79991-6, 79992-4, 79993-2).

    Measure Section: QDM Data Elements

    Source of Change: Annual Update

  • Value set Beta Blocker Therapy (2.16.840.1.113883.3.526.3.1174): Deleted 1 RXNORM code (198005).

    Measure Section: QDM Data Elements

    Source of Change: Annual Update

  • Value set Beta Blocker Therapy Ingredient (2.16.840.1.113883.3.526.3.1493): Deleted 37 RXNORM codes.

    Measure Section: QDM Data Elements

    Source of Change: Annual Update

  • Value set Beta Blocker Therapy (2.16.840.1.113883.3.526.3.1174): Added 3 RXNORM codes (1923422, 1923424, 1923426) and deleted 6 RXNORM codes (310811, 904567, 904579, 904601, 978577, 978581).

    Measure Section: QDM Data Elements

    Source of Change: 2018 Addendum

  • Value set Heart Failure (2.16.840.1.113883.3.526.3.376): Added 9 ICD10CM codes (I50.810, I50.811, I50.812, I50.813, I50.814, I50.82, I50.83, I50.84, I50.89).

    Measure Section: QDM Data Elements

    Source of Change: 2018 Addendum

Last Updated: Aug 19, 2019